М. V. Maevskaya

2 ta ish

Sechenov University

1. Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease

   M. Yu. Nadinskaia, М. V. Maevskaya, В. Т. Ивашкин +9

   MaqolaOAOchiq kirishLiver Disease Diagnosis and TreatmentWorld Journal of Gastroenterology20211 iqtibos

   ABIABI:AkademIndex/2021.article.000032

2. Results of the Interdisciplinary International Expert Council on Addressing the Management of Patients with Non-Alcoholic (Metabolic Dysfunction- Associated) Fatty Liver Disease

   М. V. Maevskaya, Sergey V. Okovityi, И. Г. Бакулин +22

   MaqolaOAOchiq kirish20260 iqtibos

   ABIABI:AkademIndex/2026.article.064681